Translate Bio Inc (TBIO)

NASDAQ
37.36
0.00(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    37.16 - 37.64
  • Type:Equity
  • Market:United States
  • ISIN:US89374L1044
  • CUSIP:00089374L104

TBIO Overview

Prev. Close
37.36
Day's Range
37.16-37.64
Revenue
225.09M
Open
37.42
52 wk Range
12.51-37.98
EPS
0.5
Volume
0
Market Cap
2.82B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
3,639,033
P/E Ratio
74.64
Beta
-
1-Year Change
153.29%
Shares Outstanding
75,590,892
Next Earnings Date
Nov. 11, 2021
What is your sentiment on Translate Bio Inc?
or
Market is currently closed. Voting is open during market hours.

Translate Bio Inc News

Translate Bio Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellBuyStrong Buy

Translate Bio Inc Company Profile

Translate Bio Inc Company Profile

Employees
122

Translate Bio, Inc., a clinical-stage messenger RNA (mRNA) therapeutics company, develops medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, which is in Phase I/II clinical trial for the treatment of cystic fibrosis. It is also developing MRT5500 for the treatment of SARS-CoV-2. The company was formerly known as RaNA Therapeutics, Inc. and changed its name to Translate Bio, Inc. in June 2017. Translate Bio, Inc. has a collaboration and license agreement with Sanofi Pasteur Inc. The company was founded in 2011 and is headquartered in Lexington, Massachusetts. As of September 13, 2021, Translate Bio, Inc. operates as a subsidiary of Sanofi.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.